ReadiGraft® Demineralized Cortical Chips

Download the files in the language of your choice
Instructions for Use
Product Specifications

ReadiGRAFT®

ReadiGraft® Demineralized Cortical Chips

Demineralized bone chips and particulates designed to promote bone healing in patients with a high risk of non-union

  • Osteoinductive Potential: Demineralized using proprietary PAD® technology that targets optimal residual calcium levels of 1-4% without compromising the grafts inherent osteoconductive properties or osteoinductive potential1-4
  • Osteoconductive: Natural bone matrix facilitates cell attachment and proliferation, and vascular in-growth
  • Sterile: Sterilized using proprietary and patented Allowash XG® technology which provides a sterility assurance level of 10-6, without compromising the graft’s inherent osteoconductive properties5
  • Versatile: Available in multiple sizes and volumes to meet surgical needs
  • Absorbent: Absorbs and retains bioactive fluids like blood, platelet rich plasma (PRP), and bone marrow aspirate (BMA)
Clinical Application
  • Any surgical application that requires bone void filler
Freeze-Dried Description Sizing
DGC20 Demineralized Cortical Chips 125 - 1000 microns 20 cc
DGC40 Demineralized Cortical Chips 125 - 1000 microns  40 cc
References
  1. Zhang M, Powers R, Wolfinbarger L. (1997). Effect(s) of demineralization process on the osteoinductivity of demineralized bone matrix. J Periodontol, 68:1085-1092. 
  2. Turonis JW, McPherson JC 3rd, Cuening MF. (2006). The affects of residual calcium in decalcified freeze-dried bone allograft in a critical-sized defect in the Rattus norvegicus calvarium. J Oral Implantol. 32(2), 55-62.
  3. Herold RW, Pashley DH, Cuening MF. (2002). Effects of varying degrees of allograft decalcification on the cultured porcine osteoclast cells. J Periodontol, 72(2), 213-219.
  4. Mott DA, Mailhot J, Cuenin MF, Sharawy M, Borke J. (2002). Enhancement of osteoblast proliferation in vitro by selective enrichment of demineralized freeze-dried bone allograft with specific growth factors. J Oral Implantiol, 28(2), 57-66.
  5. Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG®.” 2007 Bio-Implants Brief.